The adult with fontan physiology: Systematic approach to perioperative management for noncardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 2, 2011, Pages 320-334

  Eagle, Susan S ^a   Daves, Suanne M ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

adult congenital heart disease; Fontan; noncardiac surgery; perioperative management

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANXIOLYTIC AGENT; BOSENTAN; CARBON DIOXIDE; CISATRACURIUM; CORTICOSTEROID; DOBUTAMINE; ERGOMETRINE; ETOMIDATE; GLYCERYL TRINITRATE; INOTROPIC AGENT; KETAMINE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM ION; METHYLERGOMETRINE; MIDAZOLAM; MILRINONE; MIVACURIUM; NARCOTIC AGENT; NITRIC OXIDE; OXYTOCIN; PROPOFOL; ROCURONIUM; SPIRONOLACTONE; SUXAMETHONIUM; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; VECURONIUM; WARFARIN;

ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; ARTERIAL GAS; ARTIFICIAL VENTILATION; BACTERIAL ENDOCARDITIS; BLOOD GAS ANALYSIS; BLOOD PRESSURE MEASUREMENT; BRONCHITIS; CARDIAC PATIENT; CARDIOMEGALY; CARDIOPULMONARY BYPASS; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR RISK; CAVOPULMONARY CONNECTION; CENTRAL VENOUS PRESSURE; CEREBROVASCULAR ACCIDENT; CONGENITAL HEART DISEASE; CONSERVATIVE TREATMENT; CORONARY ARTERY SPASM; CROUPOUS BRONCHITIS; DEFIBRILLATOR; DRUG SAFETY; ENDOCARDITIS; EPIDURAL ANESTHESIA; EXERCISE TOLERANCE; FENESTRATION; FONTAN PROCEDURE; FORWARD HEART FAILURE; FUNCTIONAL STATUS; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM PRESSURE; HEART CATHETERIZATION; HEART FAILURE; HEART OUTPUT; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; HYPERCAPNIA; HYPOVENTILATION; HYPOXEMIA; INFERIOR CAVA VEIN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LOW DRUG DOSE; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG EDEMA; LUNG VASCULAR RESISTANCE; LUNG VOLUME; MEDICAL HISTORY; MORTALITY; MYOCARDIAL DEPRESSION; MYOCARDIAL DISEASE; OBSTETRIC ANESTHESIA; OXYGEN CONSUMPTION; OXYGEN SATURATION; PALLIATIVE THERAPY; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PATIENT MONITORING; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PLEURA EFFUSION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY HYPERTENSION; QRS COMPLEX; REVIEW; SIDE EFFECT; SPINAL ANESTHESIA; STROKE; SURVIVAL RATE; SYSTEMIC CIRCULATION; SYSTEMIC THERAPY; THERAPY EFFECT; THORAX PRESSURE; THORAX RADIOGRAPHY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT PLANNING; VENOUS RETURN;

ADULT; AGE FACTORS; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; PERIOPERATIVE CARE; PULMONARY CIRCULATION;

EID: 79954443857     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.12.003     Document Type: Review

References (142)

1. Fontan F, Baudet E: Surgical repair of tricuspid atresia. Thorax 26:240-248, 1971
2. Takeuchi K, McGowan FX Jr, Bacha EA, et al: Analysis of surgical outcome in complex double-outlet right ventricle with heterotaxy syndrome or complete atrioventricular canal defect. Ann Thorac Surg 82:146-152, 2006
3. Kawahira Y, Uemura H, Yoshikawa Y, et al: Double inlet right ventricle versus other types of double or common inlet ventricle: Its clinical characteristics with reference to the Fontan procedure. Eur J Cardiothorac Surg 20:228-232, 2001 (Pubitemid 32706599)
4. Anagnostopoulos PV, Pearl JM, Octave C, et al: Improved current era outcomes in patients with heterotaxy syndromes. Eur J Cardiothorac Surg 35:871-877, 2009
5. Vyas H, Hagler DJ: Double inlet left ventricle. Curr Treat Options Cardiovasc Med 9:391-398, 2007 (Pubitemid 47497001)
6. de Vivie ER, Ruschewski W, Koveker G, et al: Fontan procedure - Indication and clinical results. Thorac Cardiovasc Surg 29:348-354, 1981 (Pubitemid 12249002)
7. Khairy P, Fernandes SM, Mayer JE Jr, et al: Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85-92, 2008 (Pubitemid 350291185)
8. Brown JW, Ruzmetov M, Deschner BW, et al: Lateral tunnel Fontan in the current era: Is it still a good option? Ann Thorac Surg 89:556-562, 2010
9. D'Udekem Y, Cheung MM, Setyapranata S, et al: How good is a good Fontan? Quality of life and exercise capacity of Fontans without arrhythmias. Ann Thorac Surg 88:1961-1969, 2009
10. Driscoll DJ: Long-term results of the Fontan operation. Pediatr Cardiol 28:438-442, 2007
11. Hedequist DJ, Emans JB, Hall JE: Operative treatment of scoliosis in patients with a Fontan circulation. Spine 31:202-205, 2006 (Pubitemid 43117710)
12. Cannesson M, Earing MG, Collange V, et al: Anesthesia for noncardiac surgery in adults with congenital heart disease. Anesthesiology 111:432-440, 2009
13. McClain CD, McGowan FX, Kovatsis PG: Laparoscopic surgery in a patient with Fontan physiology. Anesth Analg 103:856-858, 2006 (Pubitemid 44576684)
14. Nitsche JF, Phillips SD, Rose CH, et al: Pregnancy and delivery in patients with fontan circulation: A case report and review of obstetric management. Obstet Gynecol Surv 64:607-614, 2009
15. Warnes CA, Williams RG, Bashore TM, et al: ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 118:e714-e833, 2008
16. de Leval MR, Deanfield JE: Four decades of Fontan palliation. Nat Rev Cardiol 7:520-527, 2010
17. de Leval MR, Kilner P, Gewillig M, et al: Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 96:682-695, 1988
18. van Son JA, Mohr FW, Hambsch J, et al: Conversion of atriopulmonary or lateral atrial tunnel cavopulmonary anastomosis to extracardiac conduit Fontan modification. Eur J Cardiothorac Surg 15:150-157, 1999
19. Sheikh AM, Tang AT, Roman K, et al: The failing Fontan circulation: Successful conversion of atriopulmonary connections. J Thorac Cardiovasc Surg 128:60-66, 2004 (Pubitemid 38881197)
20. Chassot PG, Bettex DA: Anesthesia and adult congenital heart disease. J Cardiothorac Vasc Anesth 20:414-437, 2006
21. Sommer RJ, Hijazi ZM, Rhodes JF: Pathophysiology of congenital heart disease in the adult: Part III: Complex congenital heart disease. Circulation 117:1340-1350, 2008 (Pubitemid 351365664)
22. Meadows J, Lang P, Marx G, et al: Fontan fenestration closure has no acute effect on exercise capacity but improves ventilatory response to exercise. J Am Coll Cardiol 52:108-113, 2008 (Pubitemid 351885447)
23. Ono M, Boethig D, Goerler H, et al: Clinical outcome of patients 20 years after Fontan operation - Effect of fenestration on late morbidity. Eur J Cardiothorac Surg 30:923-929, 2006 (Pubitemid 44738628)
24. Ghanayem NS, Berger S, Tweddell JS: Medical management of the failing Fontan. Pediatr Cardiol 28:465-471, 2007 (Pubitemid 350160291)
25. Mace L, Dervanian P, Bourriez A, et al: Changes in venous return parameters associated with univentricular Fontan circulations. Am J Physiol Heart Circ Physiol 279:H2335-2343, 2000
26. Walker SG, Stuth EA: Single-ventricle physiology: Perioperative implications. Semin Pediatr Surg 13:188-202, 2004 (Pubitemid 38953175)
27. de Leval MR: The Fontan circulation: What have we learned? What to expect? Pediatr Cardiol 19:316-320, 1998
28. de Leval MR: The Fontan circulation: A challenge to William Harvey? Nat Clin Pract Cardiovasc Med 2:202-208, 2005
29. Fontan F, Kirklin JW, Fernandez G, et al: Outcome after a "perfect" Fontan operation. Circulation 81:1520-1536, 1990
30. d'Udekem Y, Iyengar AJ, Cochrane AD, et al: The Fontan procedure: Contemporary techniques have improved long-term outcomes. Circulation 116:157-164, 2007
31. Diller G-P, Dimopoulos K, Okonko D, et al: Exercise intolerance in adult congenital heart disease: Comparative severity, correlates, and prognostic implication. Circulation 112:828-835, 2005 (Pubitemid 41170068)
32. Takken T, Tacken MH, Blank AC, et al: Exercise limitation in patients with Fontan circulation: A review. J Cardiovasc Med (Hagerstown) 8:775-781, 2007 (Pubitemid 47476414)
33. Mavroudis C, Deal BJ, Backer CL: Arrhythmia surgery in association with complex congenital heart repairs excluding patients with Fontan conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 6:33-50, 2003
34. Norozi K, Wessel A, Alpers V, et al: Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol 97:1238-1243, 2006
35. Westhoff-Bleck M, Norozi K, Schoof S, et al: QRS duration in Fontan circulation in adults: A predictor of aerobic capacity. Int J Cardiol 132:375-381, 2009
36. van den Bosch AE, Roos-Hesselink JW, Van Domburg R, et al: Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol 93:1141-1145, 2004 (Pubitemid 38521044)
37. Gersony WM: Fontan operation after 3 decades: what we have learned. Circulation 117:13-15, 2008
38. Piran S, Veldtman G, Siu S, et al: Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 105:1189-1194, 2002 (Pubitemid 34225819)
39. Senzaki H, Masutani S, Ishido H, et al: Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol 47:2528-2535, 2006 (Pubitemid 43866371)
40. Fogel MA, Weinberg PM, Chin AJ, et al: Late ventricular geometry and performance changes of functional single ventricle throughout staged Fontan reconstruction assessed by magnetic resonance imaging. J Am Coll Cardiol 28:212-221, 1996 (Pubitemid 26266643)
41. Fogel MA, Weinberg PM, Fellows KE, et al: A study in ventricular- ventricular interaction. Single right ventricles compared with systemic right ventricles in a dual-chamber circulation. Circulation 92:219-230, 1995
42. Diller GP, Dimopoulos K, Okonko D, et al: Heart rate response during exercise predicts survival in adults with congenital heart disease. J Am Coll Cardiol 48:1250-1256, 2006 (Pubitemid 44345139)
43. Goldstein BH, Connor CE, Gooding L, et al: Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation. Am J Cardiol 105:1169-1175, 2010
44. Kim SJ, Kim WH, Lim HG, et al: Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 136:108-116, 2008
45. Constantine M, Carl Lewis B, Barbara JD, et al: Evolving anatomic and electrophysiologic considerations associated with Fontan conversion. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 10:136-145, 2007
46. Mavroudis C, Deal BJ, Backer CL, et al: J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: Surgical lessons and outcomes. Ann Thorac Surg 84:1457-1465, 2007
47. Deal BJ, Mavroudis C, Backer CL: Arrhythmia management in the Fontan patient. Pediatr Cardiol 28:448-456, 2007 (Pubitemid 350160289)
48. Rathod RH, Prakash A, Powell AJ, et al: Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol 55:1721-1728, 2010
49. Koh M, Uemura H, Kada A, et al: Chronologic changes in P-wave characteristics after the Fontan procedure: The effect of surgical modification. J Thorac Cardiovasc Surg 140:137-143, 2010
50. Rao SO, Boramanand NK, Burton DA, et al: Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol. Int J Cardiol 136:253-257, 2009
51. Lopez JA: Transvenous right atrial and left ventricular pacing after the Fontan operation: Long-term hemodynamic and electrophysiologic benefit of early atrioventricular resynchronization. Tex Heart Inst J 34:98-101, 2007
52. Estner HL, Kolb C, Schmitt C, et al: Long-term transvenous AV-sequential pacing in a failing atriopulmonary Fontan patient. Int J Cardiol 127:e93-95, 2008
53. Stephenson EA, Lu M, Berul CI, et al: Arrhythmias in a contemporary Fontan cohort: Prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol 56:890-896, 2010
54. Lovell AT: Anaesthetic implications of grown-up congenital heart disease. Br J Anaesth 93:129-139, 2004
55. Deal BJ, Mavroudis C, Backer CL: Beyond Fontan conversion: Surgical therapy of arrhythmias including patients with associated complex congenital heart disease. Ann Thorac Surg 76:542-553, 2003
56. Dave AS, Aboulhosn J, Child JS, et al: Transconduit puncture for catheter ablation of atrial tachycardia in a patient with extracardiac Fontan palliation. Heart Rhythm 7:413-416, 2010
57. Morales DL, Dibardino DJ, Braud BE, et al: Salvaging the failing Fontan: Lateral tunnel versus extracardiac conduit. Ann Thorac Surg 80:1445-1451, 2005
58. Epstein AE, DiMarco JP, Ellenbogen KA, et al: ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51:e1-e62, 2008
59. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: Pacemakers and implantable cardioverterdefibrillators: A report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology 103:186-198, 2005
60. Barber BJ, Batra AS, Burch GH, et al: Acute hemodynamic effects of pacing in patients with Fontan physiology: A prospective study. J Am Coll Cardiol 46:1937-1942, 2005
61. Mascio CE, Wayment M, Colaizy TT, et al: The modified Fontan procedure and prolonged pleural effusions. Am Surg 75:175-177, 2009
62. Yun TJ, Im YM, Jung SH, et al: Pulmonary vascular compliance and pleural effusion duration after the Fontan procedure. Int J Cardiol 133:55-61, 2009
63. Gupta A, Daggett C, Behera S, et al: Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. J Thorac Cardiovasc Surg 127:1664-1669, 2004 (Pubitemid 38725445)
64. Fedderly RT, Whitstone BN, Frisbee SJ, et al: Factors related to pleural effusions after Fontan procedure in the era of fenestration. Circulation 104:I148-I151, 2001 (Pubitemid 32884794)
65. Griffiths ER, Kaza AK, Wyler von Ballmoos MC, et al: Evaluating failing Fontans for heart transplantation: Predictors of death. Ann Thorac Surg 88:558-563, 2009
66. Zaccagni HJ, Kirchner L, Brownlee J, et al: A case of plastic bronchitis presenting 9 years after Fontan. Pediatr Cardiol 29:157-159, 2008
67. Apostolopoulou SC, Papagiannis J, Rammos S: Bosentan induces clinical, exercise and hemodynamic improvement in a pretransplant patient with plastic bronchitis after Fontan operation. J Heart Lung Transplant 24:1174-1176, 2005 (Pubitemid 41127216)
68. Chen J, Zimmerman RA, Jarvik GP, et al: Perioperative stroke in infants undergoing open heart operations for congenital heart disease. Ann Thorac Surg 88:823-829, 2009
69. du Plessis AJ, Chang AC, Wessel DL, et al: Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 12:230-236, 1995
70. Day RW, Boyer RS, Tait VF, et al: Factors associated with stroke following the Fontan procedure. Pediatr Cardiol 16:270-275, 1995
71. Padalino MA, Cogo PE, Daliento L, et al: Congenital heart disease in adults: An 8-year surgical experience in a medium-volume cardiac center. J Cardiovasc Med (Hagerstown) 11:175-181, 2010
72. Seipelt RG, Franke A, Vazquez-Jimenez JF, et al: Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 74:556-562, 2002 (Pubitemid 34838867)
73. Umar SB, DiBaise JK: Protein-losing enteropathy: Case illustrations and clinical review. Am J Gastroenterol 105:43-49, 2010
74. Silvilairat S, Cabalka AK, Cetta F, et al: Protein-losing enteropathy after the Fontan operation: Associations and predictors of clinical outcome. Congenit Heart Dis 3:262-268, 2008
75. Powell AJ, Gauvreau K, Jenkins KJ, et al: Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure. Am J Cardiol 88:1206-1209, 2001 (Pubitemid 33043863)
76. Rychik J: Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2:288-300, 2007
77. Feldt RH, Driscoll DJ, Offord KP, et al: Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 112:672-680, 1996 (Pubitemid 26347022)
78. Ostrow AM, Freeze H, Rychik J: Protein-losing enteropathy after Fontan operation: Investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 82:695-700, 2006 (Pubitemid 44080020)
79. Bode L, Freeze HH: Applied glycoproteomics - Approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim Biophys Acta 1760:547-559, 2006
80. Meadows J, Gauvreau K, Jenkins K: Lymphatic obstruction and protein losing enteropathy in patients with congenital heart disease. Congenit Heart Dis 3:269-276, 2008
81. Rychik J, Spray TL: Strategies to treat protein-losing enteropathy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:3-11, 2002 (Pubitemid 38202146)
82. Marcelletti CF, Hanley FL, Mavroudis C, et al: Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multicenter experience. J Thorac Cardiovasc Surg 119:340-346, 2000 (Pubitemid 30091808)
83. Thacker D, Patel A, Dodds K, et al: Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 89:837-842, 2010
84. Bhagirath KM, Tam JW: Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation. Ann Thorac Surg 84:2110-2112, 2007 (Pubitemid 350122405)
85. Rychik J, Piccoli DA, Barber G: Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol 68:819-821, 1991
86. Camposilvan S, Milanesi O, Stellin G, et al: Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 86:177-182, 2008
87. Kiesewetter CH, Sheron N, Vettukattill JJ, et al: Hepatic changes in the failing Fontan circulation. Heart 93:579-584, 2007 (Pubitemid 46707109)
88. Muilenburg DJ, Singh A, Torzilli G, et al: Surgery in the patient with liver disease. Anesthesiol Clin 27:721-737, 2009
89. Dimopoulos K, Diller GP, Koltsida E, et al: Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117:2320-2328, 2008 (Pubitemid 351681557)
90. Anne P, Du W, Mattoo TK, et al: Nephropathy in patients after Fontan palliation. Int J Cardiol 132:244-247, 2009
91. Powell AJ: Aortopulmonary collaterals in single-ventricle congenital heart disease: How much do they count? Circ Cardiovasc Imaging 2:171-173, 2009
92. Kirk RK, Robert NV: Management of aortopulmonary collateral arteries in Fontan patients: Occlusion improves clinical outcome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:48-54, 2002
93. Scott MB: Management of aortopulmonary collateral arteries in Fontan patients: Routine occlusion is not warranted. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5:55-67, 2002
94. Masura J, Bordacova L, Tittel P, et al: Percutaneous management of cyanosis in Fontan patients using Amplatzer occluders. Catheter Cardiovasc Interv 71:843-849, 2008 (Pubitemid 351656338)
95. Justino H, Benson LN, Freedom RM: Development of unilateral pulmonary arteriovenous malformations due to unequal distribution of hepatic venous flow. Circulation 103:E39-E40, 2001
96. Jacobs ML, Pourmoghadam KK, Geary EM, et al: Pulmonary arteriovenous malformations after cavopulmonary connection. Ann Thorac Surg 69:634-635, 2000 (Pubitemid 30125615)
97. Pike NA, Vricella LA, Feinstein JA, et al: Regression of severe pulmonary arteriovenous malformations after Fontan revision and "hepatic factor" rerouting. Ann Thorac Surg 78:697-699, 2004 (Pubitemid 38980806)
98. Shah MJ, Rychik J, Fogel MA, et al: Pulmonary AV malformations after superior cavopulmonary connection: Resolution after inclusion of hepatic veins in the pulmonary circulation. Ann Thorac Surg 63:960-963, 1997 (Pubitemid 27191644)
99. Shah H, Kuehl K, Sherker AH: Liver disease after the Fontan procedure: What the hepatologist needs to know. J Clin Gastroenterol 44:428-431, 2010
100. Weber HS: Incidence and predictors for the development of significant supradiaphragmatic decompressing venous collateral channels following creation of Fontan physiology. Cardiol Young 11:289-294, 2001
101. Magee AG, McCrindle BW, Mawson J, et al: Systemic venous collateral development after the bidirectional cavopulmonary anastomosis. Prevalence and predictors. J Am Coll Cardiol 32:502-508, 1998 (Pubitemid 28396504)
102. Fletcher SE, Case CL, Fyfe DA, et al: Clinical spectrum of venous thrombi in the Fontan patient. Am J Cardiol 68:1721-1722, 1991
103. Tsang W, Johansson B, Salehian O, et al: Intracardiac thrombus in adults with the Fontan circulation. Cardiol Young 17:646-651, 2007 (Pubitemid 350154101)
104. Bartz PJ, Driscoll DJ, Dearani JA, et al: Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients. J Am Coll Cardiol 48:2301-2305, 2006 (Pubitemid 44855420)
105. Varma C, Warr MR, Hendler AL, et al: Prevalence of "silent" pulmonary emboli in adults after the Fontan operation. J Am Coll Cardiol 41:2252-2258, 2003 (Pubitemid 36724276)
106. Odegard KC, Zurakowski D, DiNardo JA, et al: Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. J Thorac Cardiovasc Surg 137:934-941, 2009
107. Odegard KC, McGowan FX Jr, Zurakowski D, et al: Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: Increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 125:1260-1267, 2003 (Pubitemid 36759223)
108. Kajimoto H, Nakazawa M, Murasaki K, et al: Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients. Circ J 73:1705-1710, 2009
109. Binotto MA, Maeda NY, Lopes AA: Altered endothelial function following the Fontan procedure. Cardiol Young 18:70-74, 2008 (Pubitemid 351228072)
110. Jacobs ML, Pourmoghadam KK: Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol 28:457-464, 2007 (Pubitemid 350160290)
111. Walker HA, Gatzoulis MA: Prophylactic anticoagulation following the Fontan operation. Heart 91:854-856, 2005 (Pubitemid 40874062)
112. Collins N, Piran S, Harrison J, et al: Prevalence and determinants of anemia in adults with complex congenital heart disease and ventricular dysfunction (subaortic right ventricle and single ventricle physiology). Am J Cardiol 102:625-628, 2008
113. Dimopoulos K, Diller GP, Petraco R, et al: Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. Eur Heart J 31:595-601, 2010
114. Ohuchi H, Miyamoto Y, Yamamoto M, et al: High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J 158:30-39, 2009
115. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 112:1084-1096, 2010
116. Engelfriet P, Boersma E, Oechslin E, et al: The spectrum of adult congenital heart disease in Europe: Morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 26:2325-2333, 2005
117. Lim DS, Graziano JN, Rocchini AP, et al: Transcatheter occlusion of aortopulmonary shunts during single-ventricle surgical palliation. Catheter Cardiovasc Interv 65:427-433, 2005 (Pubitemid 40898189)
118. Crowley DI, Donnelly JP: Use of Amplatzer occlusion devices to occlude Fontan baffle leaks during fenestration closure procedures. Catheter Cardiovasc Interv 71:244-249, 2008 (Pubitemid 351293773)
119. Grosse-Wortmann L, Al-Otay A, Yoo SJ: Aortopulmonary collaterals after bidirectional cavopulmonary connection or Fontan completion: Quantification with MRI. Circ Cardiovasc Imaging 2:219-225, 2009
120. Takawira F, Ayer JG, Onikul E, et al: Evaluation of the extracardiac conduit modification of the Fontan operation for thrombus formation using magnetic resonance imaging. Heart Lung Circ 17:407-410, 2008
121. Fratz S, Hess J, Schwaiger M, et al: More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion scintigraphy in patients with Fontan circulation. Circulation 106:1510-1513, 2002
122. Milhoan KA, Levy DJ, Shields N, et al: Upper extremity peripheral venous pressure measurements accurately reflect pulmonary artery pressures in patients with cavopulmonary or Fontan connections. Pediatr Cardiol 25:17-19, 2004 (Pubitemid 38140850)
123. Thompson LD, Petrossian E, McElhinney DB, et al: Is it necessary to routinely fenestrate an extracardiac Fontan? J Am Coll Cardiol 34:539-544, 1999
124. Cai J, Su Z, Shi Z, et al: Nitric oxide and milrinone: Combined effect on pulmonary circulation after Fontan-type procedure: A prospective, randomized study. Ann Thorac Surg 86:882-888, 2008
125. Khambadkone S, Li J, de Leval MR, et al: Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation 107:3204-3208, 2003 (Pubitemid 36793092)
126. Sprung J, Ogletree-Hughes ML, Moravec CS: The effects of etomidate on the contractility of failing and nonfailing human heart muscle. Anesth Analg 91:68-75, 2000 (Pubitemid 30437063)
127. Andropoulos DB, Stayer SA, Skjonsby BS, et al: Anesthetic and perioperative outcome of teenagers and adults with congenital heart disease. J Cardiothorac Vasc Anesth 16:731-736, 2002 (Pubitemid 36076462)
128. Naguib M, Samarkandi AH, Bakhamees HS, et al: Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 75:588-592, 1995
129. Redington AN, Penny D, Shinebourne EA: Pulmonary blood flow after total cavopulmonary shunt. Br Heart J 65:213-217, 1991
130. Shekerdemian LS, Bush A, Shore DF, et al: Cardiopulmonary interactions after Fontan operations: Augmentation of cardiac output using negative pressure ventilation. Circulation 96:3934-3942, 1997
131. Fogel MA, Weinberg PM, Hoydu A, et al: The nature of flow in the systemic venous pathway measured by magnetic resonance blood tagging in patients having the Fontan operation. J Thorac Cardiovasc Surg 114:1032-1041, 1997 (Pubitemid 28023885)
132. Lofland GK: The enhancement of hemodynamic performance in Fontan circulation using pain free spontaneous ventilation. Eur J Cardiothorac Surg 20:114-118, 2001
133. Bailey PD Jr, Jobes DR: The Fontan patient. Anesthesiol Clin 27:285-300, 2009
134. Leyvi G, Wasnick JD: Single-ventricle patient: Pathophysiology and anesthetic management. J Cardiothorac Vasc Anesth 24:121-130, 2010
135. Cattano D, Nicolini A, Genovesi M, et al: Laparoscopic cholecystectomy in an adult with complex-corrected congenital heart disease. Anesth Analg 104:242-243, 2007 (Pubitemid 46360511)
136. Carp H, Jayaram A, Vadhera R, et al: Epidural anesthesia for cesarean delivery and vaginal birth after maternal Fontan repair: Report of two cases. Anesth Analg 78:1190-1192, 1994 (Pubitemid 24164376)
137. Ioscovich A, Briskin A, Fadeev A, et al: Emergency cesarean section in a patient with Fontan circulation using an indwelling epidural catheter. J Clin Anesth 18:631-634, 2006 (Pubitemid 44908946)
138. Horlocker TT, Wedel DJ, Rowlingson JC, et al: Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 35:64-101, 2010
139. Hayashi Y, Ibe T, Kawato H, et al: Postpartum acute myocardial infarction induced by ergonovine administration. Intern Med 42:983-986, 2003 (Pubitemid 37407644)
140. Hankins GD, Berryman GK, Scott RT Jr, et al: Maternal arterial desaturation with 15-methyl prostaglandin F2 alpha for uterine atony. Obstet Gynecol 72:367-370, 1988
141. Wilson W, Taubert KA, Gewitz M, et al: Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116:1736-1754, 2007
142. Silversides CK, Salehian O, Oechslin E, et al: Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Complex congenital cardiac lesions. Can J Cardiol 26:e98-e117, 2010